Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	IDXXIdexx Laboratories	BDXBecton Dickinson	EWEdwards Lifesciences
Snapshot
Price	$543.68	$189.44	$91.23
Market cap	$44.00B	$43.56B	$54.34B
Valuation
P/E	39.2x	46.1x	47.9x
Forward P/E	31.2x	61.3x	68.4x
Growth
Revenue growth	13.1%	2.4%	13.8%
EPS growth	25.6%	-24.8%	-73.2%
Profitability
Net margin	24.6%	5.3%	17.4%
ROE	70.9%	4.5%	10.6%
Balance sheet & cash
Debt / equity	0.53x	0.76x	0.06x
Free cash flow yield	1.9%	9.0%	2.9%
Dividend yield	—	2.9%	—
Verdict
Investment rating	Favorable· 69	Weak· 32	Neutral· 47

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	IDXXtoday $544	BDXtoday $189	EWtoday $91
2027	$512.11 – $751.09+38% CAGR	$144.92 – $212.55+12% CAGR	$69.79 – $102.36+12% CAGR
2028	$643.15 – $943.29+32% CAGR	$147.82 – $216.80+7% CAGR	$71.19 – $104.41+7% CAGR
2029	$807.74 – $1,184.68+30% CAGR	$150.78 – $221.14+5% CAGR	$72.61 – $106.50+5% CAGR
2030	$1,014.44 – $1,487.84+29% CAGR	$153.79 – $225.56+4% CAGR	$74.06 – $108.63+4% CAGR
2031	$1,274.03 – $1,868.58+28% CAGR	$156.87 – $230.07+4% CAGR	$75.54 – $110.80+4% CAGR
5-yr CAGR	18.6% – 28.0%	-3.7% – 4.0%	-3.7% – 4.0%